Global Liver Transplantation Market

Global Liver Transplantation Market Key Players Competitive Survey Report 2023

Global Liver Transplantation Market

Global Liver Transplantation Market Key Players Competitive Survey Report 2023


Liver Transplantation Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.


Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Liver Transplantation market size in 2022 is 1500.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 6.70% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Liver Transplantation market include AlloSource (U.S.), SJ Corporation Limited (U.S.), Dompé farmaceutici S.p.A. (Italy), Thompson Surgical (U.S.), and Integra Life Sciences (U.S.). The share of the top 3 players in the Liver Transplantation market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Liver Transplantation market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Organ Preservation Solutions accounted for XX% of Liver Transplantation market in 2022. Immunosuppressive Drugs share of XX%.

Hospitals accounted for XX% of the Liver Transplantation market in 2022. Transplant Centres accounts for XX%.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

COVID-19 Impact:

Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Liver Transplantation market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.

The report analyzes the key trends in each segment of the global Liver Transplantation market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.

Key benefits to stakeholders:

The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Liver Transplantation market for 2017-2028.

The research report provides the latest information on the market drivers, challenges and opportunities of the global Liver Transplantation market.

The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.

Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Liver Transplantation industry and its attractiveness.

The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Spain

Nordic

Asia Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Egypt

South Africa

UAE

Turkey

Saudi Arabia

Player list

AlloSource (U.S.)

SJ Corporation Limited (U.S.)

Dompé farmaceutici S.p.A. (Italy)

Thompson Surgical (U.S.)

Integra Life Sciences (U.S.)

AbbVie Inc. (U.S.)

North Chicago Illinois (U.S.)

Arthrex Inc (U.S.)

Zimmer Biomet (U.S.)

Medtronic (Ireland)

Novartis AG (Germany)

Stryker (U.S.)

21st Century Medicine (U.S.)

BioLife Solutions (U.S.)

Teva Pharmaceutical Industries Ltd. (Israel )

Veloxis Pharmaceuticals Inc (U.S.)

RedHill Biopharma Ltd. (Israel)

Types list

Organ Preservation Solutions

Immunosuppressive Drugs

Others

Application list

Hospitals

Transplant Centres

Ambulatory Surgical Centres

Others

Table of Content

1 Liver Transplantation Market Introduction and Overview

1.1 Liver Transplantation Definition

1.2 Research Purposes

1.3 Report Timeline

1.4 Economic Analysis of Global Regions

1.5 Inflation Analysis

1.6 The Impact of the Russian-Ukrainian War on the Market

1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global

2 Global Liver Transplantation Historical Market Analysis by Type

2.1 Market Size Analysis by Types

2.2 Global Liver Transplantation Revenue and Market Share by Type

3 Global Liver Transplantation Historical Market Analysis by Application

3.1 Market Size Analysis by Application

3.2 Global Liver Transplantation Revenue Market Share by Application (2018-2023)

4 Global Market Growth Trends Analysis

4.1 Global Liver Transplantation Market Size (2018-2023)

4.2 Liver Transplantation Growth Trends Analysis by Regions

4.2.1 Liver Transplantation Market Size by Regions: 2018 VS 2023 VS 2029

4.2.2 Liver Transplantation Historic Revenue Market Size by Regions (2018-2023)

4.2.3 North America Liver Transplantation Market Size (2018-2023)

4.2.4 Europe Liver Transplantation Market Size (2018-2023)

4.2.5 Asia-Pacific Liver Transplantation Market Size (2018-2023)

4.2.6 Latin America Liver Transplantation Market Size (2018-2023)

4.2.7 Middle East & Africa Liver Transplantation Market Size (2018-2023)

5 North America

5.1 North America Liver Transplantation Revenue by Countries

5.1.1 North America Liver Transplantation Revenue by Countries (2018-2023)

5.2 North America Liver Transplantation Revenue by Types

5.3 North America Liver Transplantation Revenue by Applications

5.4 United States

5.5 Canada

6 Asia Pacific

6.1 Asia Pacific Liver Transplantation Revenue by Countries

6.1.1 Asia Pacific Liver Transplantation Revenue by Countries (2018-2023)

6.2 Asia Pacific Liver Transplantation Revenue by Types

6.3 Asia Pacific Liver Transplantation Revenue by Applications

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Liver Transplantation Revenue by Countries

7.1.1 Europe Liver Transplantation Revenue by Countries (2018-2023)

7.2 Europe Liver Transplantation Revenue by Types

7.3 Europe Liver Transplantation Revenue by Applications

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Nordic

8 Latin America

8.1 Latin America Liver Transplantation Revenue by Countries

8.1.1 Latin America Liver Transplantation Revenue by Countries (2018-2023)

8.2 Latin America Liver Transplantation Revenue by Types

8.3 Latin America Liver Transplantation Revenue by Applications

8.4 Brazil

8.5 Argentina

8.6 Mexico

9 Middle East & Africa

9.1 Middle East & Africa Liver Transplantation Revenue by Countries

9.1.1 Middle East & Africa Liver Transplantation Revenue by Countries (2018-2023)

9.2 Middle East & Africa Liver Transplantation Revenue by Types

9.3 Middle East & Africa Liver Transplantation Revenue by Applications

9.4 Egypt

9.5 South Africa

9.6 UAE

9.7 Turkey

9.8 Saudi Arabia

10 Global Liver Transplantation Market Competition, by Players

10.1 Global Liver Transplantation Revenue and Market Share by Players

10.2 Market Concentration Rate

10.2.1 Top 3 Liver Transplantation Players Market Share in 2022

10.2.2 Top 6 Liver Transplantation Players Market Share in 2022

10.2.3 Market Competition Trend

10.3 Liver Transplantation Players Head Office, Business Provided

10.4 Liver Transplantation Mergers & Acquisitions

10.5 Liver Transplantation New Entrants and Expansion Plans

11 Players Profiles11.1 AlloSource (U.S.)

11.1.1 AlloSource (U.S.) Company Profile

11.1.2 Liver Transplantation Product Overview

11.1.3 AlloSource (U.S.) Liver Transplantation Market Performance (2018-2023)

11.1.4 AlloSource (U.S.) Business Overview

11.1.5 Recent Developments and Plans

11.2 SJ Corporation Limited (U.S.)

11.2.1 SJ Corporation Limited (U.S.) Company Profile

11.2.2 Liver Transplantation Product Overview

11.2.3 SJ Corporation Limited (U.S.) Liver Transplantation Market Performance (2018-2023)

11.2.4 SJ Corporation Limited (U.S.) Business Overview

11.2.5 Recent Developments and Plans

11.3 Dompé farmaceutici S.p.A. (Italy)

11.3.1 Dompé farmaceutici S.p.A. (Italy) Company Profile

11.3.2 Liver Transplantation Product Overview

11.3.3 Dompé farmaceutici S.p.A. (Italy) Liver Transplantation Market Performance (2018-2023)

11.3.4 Dompé farmaceutici S.p.A. (Italy) Business Overview

11.3.5 Recent Developments and Plans

11.4 Thompson Surgical (U.S.)

11.4.1 Thompson Surgical (U.S.) Company Profile

11.4.2 Liver Transplantation Product Overview

11.4.3 Thompson Surgical (U.S.) Liver Transplantation Market Performance (2018-2023)

11.4.4 Thompson Surgical (U.S.) Business Overview

11.4.5 Recent Developments and Plans

11.5 Integra Life Sciences (U.S.)

11.5.1 Integra Life Sciences (U.S.) Company Profile

11.5.2 Liver Transplantation Product Overview

11.5.3 Integra Life Sciences (U.S.) Liver Transplantation Market Performance (2018-2023)

11.5.4 Integra Life Sciences (U.S.) Business Overview

11.5.5 Recent Developments and Plans

11.6 AbbVie Inc. (U.S.)

11.6.1 AbbVie Inc. (U.S.) Company Profile

11.6.2 Liver Transplantation Product Overview

11.6.3 AbbVie Inc. (U.S.) Liver Transplantation Market Performance (2018-2023)

11.6.4 AbbVie Inc. (U.S.) Business Overview

11.6.5 Recent Developments and Plans

11.7 North Chicago Illinois (U.S.)

11.7.1 North Chicago Illinois (U.S.) Company Profile

11.7.2 Liver Transplantation Product Overview

11.7.3 North Chicago Illinois (U.S.) Liver Transplantation Market Performance (2018-2023)

11.7.4 North Chicago Illinois (U.S.) Business Overview

11.7.5 Recent Developments and Plans

11.8 Arthrex Inc (U.S.)

11.8.1 Arthrex Inc (U.S.) Company Profile

11.8.2 Liver Transplantation Product Overview

11.8.3 Arthrex Inc (U.S.) Liver Transplantation Market Performance (2018-2023)

11.8.4 Arthrex Inc (U.S.) Business Overview

11.8.5 Recent Developments and Plans

11.9 Zimmer Biomet (U.S.)

11.9.1 Zimmer Biomet (U.S.) Company Profile

11.9.2 Liver Transplantation Product Overview

11.9.3 Zimmer Biomet (U.S.) Liver Transplantation Market Performance (2018-2023)

11.9.4 Zimmer Biomet (U.S.) Business Overview

11.9.5 Recent Developments and Plans

11.10 Medtronic (Ireland)

11.10.1 Medtronic (Ireland) Company Profile

11.10.2 Liver Transplantation Product Overview

11.10.3 Medtronic (Ireland) Liver Transplantation Market Performance (2018-2023)

11.10.4 Medtronic (Ireland) Business Overview

11.10.5 Recent Developments and Plans

11.11 Novartis AG (Germany)

11.11.1 Novartis AG (Germany) Company Profile

11.11.2 Liver Transplantation Product Overview

11.11.3 Novartis AG (Germany) Liver Transplantation Market Performance (2018-2023)

11.11.4 Novartis AG (Germany) Business Overview

11.11.5 Recent Developments and Plans

11.12 Stryker (U.S.)

11.12.1 Stryker (U.S.) Company Profile

11.12.2 Liver Transplantation Product Overview

11.12.3 Stryker (U.S.) Liver Transplantation Market Performance (2018-2023)

11.12.4 Stryker (U.S.) Business Overview

11.12.5 Recent Developments and Plans

11.13 21st Century Medicine (U.S.)

11.13.1 21st Century Medicine (U.S.) Company Profile

11.13.2 Liver Transplantation Product Overview

11.13.3 21st Century Medicine (U.S.) Liver Transplantation Market Performance (2018-2023)

11.13.4 21st Century Medicine (U.S.) Business Overview

11.13.5 Recent Developments and Plans

11.14 BioLife Solutions (U.S.)

11.14.1 BioLife Solutions (U.S.) Company Profile

11.14.2 Liver Transplantation Product Overview

11.14.3 BioLife Solutions (U.S.) Liver Transplantation Market Performance (2018-2023)

11.14.4 BioLife Solutions (U.S.) Business Overview

11.14.5 Recent Developments and Plans

11.15 Teva Pharmaceutical Industries Ltd. (Israel )

11.15.1 Teva Pharmaceutical Industries Ltd. (Israel ) Company Profile

11.15.2 Liver Transplantation Product Overview

11.15.3 Teva Pharmaceutical Industries Ltd. (Israel ) Liver Transplantation Market Performance (2018-2023)

11.15.4 Teva Pharmaceutical Industries Ltd. (Israel ) Business Overview

11.15.5 Recent Developments and Plans

11.16 Veloxis Pharmaceuticals Inc (U.S.)

11.16.1 Veloxis Pharmaceuticals Inc (U.S.) Company Profile

11.16.2 Liver Transplantation Product Overview

11.16.3 Veloxis Pharmaceuticals Inc (U.S.) Liver Transplantation Market Performance (2018-2023)

11.16.4 Veloxis Pharmaceuticals Inc (U.S.) Business Overview

11.16.5 Recent Developments and Plans

11.17 RedHill Biopharma Ltd. (Israel)

11.17.1 RedHill Biopharma Ltd. (Israel) Company Profile

11.17.2 Liver Transplantation Product Overview

11.17.3 RedHill Biopharma Ltd. (Israel) Liver Transplantation Market Performance (2018-2023)

11.17.4 RedHill Biopharma Ltd. (Israel) Business Overview

11.17.5 Recent Developments and Plans

12 Global Liver Transplantation Forecast Market Analysis by Type

12.1 Global Liver Transplantation Revenue Market Forecast by Type (2023-2029)

13 Global Liver Transplantation Forecast Market Analysis by Application

13.1 Liver Transplantation Revenue Market Forecast by Application (2023-2029)

14 Global Market Growth Forecast Analysis

14.1 Global Liver Transplantation Forecast Market Size (2023-2029)

14.2 Liver Transplantation Growth Trends Forecast Analysis by Regions

14.2.1 Liver Transplantation Revenue Forecast Market Size by Regions (2023-2029)

14.2.2 North America Liver Transplantation Forecast Market Size (2023-2029)

14.2.3 Europe Liver Transplantation Forecast Market Size (2023-2029)

14.2.4 Asia-Pacific Liver Transplantation Forecast Market Size (2023-2029)

14.2.5 Latin America Liver Transplantation Forecast Market Size (2023-2029)

14.2.6 Middle East & Africa Liver Transplantation Forecast Market Size (2023-2029)

15 Liver Transplantation Industry Dynamic Analysis

15.1 Liver Transplantation Market Trends Analysis

15.2 Liver Transplantation Market Drivers Analysis

15.3 Liver Transplantation Market Challenges Analysis

15.4 Liver Transplantation Market Restraints Analysis

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Liver Transplantation Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Liver Transplantation Market?
New players are entering the Liver Transplantation Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What are the major applications for Liver Transplantation?
Liver Transplantation has a wide range of applications, including and others.
What is the current state of the Liver Transplantation Industry, and what is the projected growth trajectory through 2030?
In 2024, the Liver Transplantation Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.
Where does the Liver Transplantation Industry stands in terms of scaling end-use implementations?
According to the Liver Transplantation Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
Who should consider the Liver Transplantation Market study?
The Liver Transplantation Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.